Guangzhou Institute of Biomedicine and Health-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Guangzhou Institute of Biomedicine and Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013276
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Guangzhou Institute of Biomedicine and Health (GIBH) is a research institute that conducts research on stem cell and regenerative medicine, chemical biology, infection and immunity, public health and scientific research equipment development. The institute’s life process and disease mechanism provide solutions to the innovation and integration of human health and disease prevention, constructing research and development base for China’s bio-medicine and health and serving national strategic demands and economic and social development. It provides mechanisms for controlling the transformation of adult cells into pluripotent stem cells (iPSCs) and optimization of protocols for directed differentiation of normal and diseased human iPSCs into different cell lineages. GIBH is headquartered in Guangzhou, China.

Guangzhou Institute of Biomedicine and Health – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Euclises Pharma Enters into Co-Development Agreement with Guangzhou Institutes of Biomedicine 10
Casigen Pharma Enters Into Co-Development Agreement With Guangzhou Institute of Biomedicine and Health 11
Ventac Partners Enters Into Joint Venture Agreement With Guangzhou Institutes of Biomedicine 12
Saint Louis University Enters Into Co-Development Agreement With Guangzhou Institute 13
Licensing Agreements 14
RaQualia Enters Into Licensing And Co-Development Agreement With A Chinese Company And Guangzhou Institutes of Biomedicine 14
Guangzhou Institute of Biomedicine and Health – Key Competitors 15
Guangzhou Institute of Biomedicine and Health – Key Employees 16
Guangzhou Institute of Biomedicine and Health – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Key Facts 2
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Guangzhou Institute of Biomedicine and Health, Deals By Therapy Area, 2011 to YTD 2017 8
Guangzhou Institute of Biomedicine and Health, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Euclises Pharma Enters into Co-Development Agreement with Guangzhou Institutes of Biomedicine 10
Casigen Pharma Enters Into Co-Development Agreement With Guangzhou Institute of Biomedicine and Health 11
Ventac Partners Enters Into Joint Venture Agreement With Guangzhou Institutes of Biomedicine 12
Saint Louis University Enters Into Co-Development Agreement With Guangzhou Institute 13
RaQualia Enters Into Licensing And Co-Development Agreement With A Chinese Company And Guangzhou Institutes of Biomedicine 14
Guangzhou Institute of Biomedicine and Health, Key Competitors 15
Guangzhou Institute of Biomedicine and Health, Key Employees 16
Guangzhou Institute of Biomedicine and Health, Joint Venture 17

★海外企業調査レポート[Guangzhou Institute of Biomedicine and Health-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shanghai Electric Group Co Ltd:戦略・SWOT・企業財務分析
    Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Sorgenia SpA:企業の戦略的SWOT分析
    Sorgenia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SpareBank 1 SMN:企業の戦略・SWOT・財務分析
    SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report Summary SpareBank 1 SMN - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報
    Summary Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technol …
  • Cellular Biomedicine Group Inc (CBMG):企業の財務・戦略的SWOT分析
    Summary Cellular Biomedicine Group Inc (CBMG) is a clinical stage biopharmaceutical firm that develops biomedicine, immunotherapy products for cancer and stem cell therapies to address patient specific medical conditions. The firm’s products comprise clinical treatment protocols for the treatment of …
  • Streck Inc:企業の製品パイプライン分析2018
    Summary Streck Inc (Streck) is a developer and manufacturer of hematology, immunology and molecular biology products for clinical and research laboratories. The company provide products such as offers body fluid, sedimentation-rate, chemistry, whole blood, whole blood glucose and hemoglobin, instrum …
  • 7C Solarparken AG (HRPK):企業の財務・戦略的SWOT分析
    Summary 7C Solarparken AG (7C Solarparken), formerly Colexon Energy AG is a renewable energy company that develops and operates photovoltaic farms. The company operates, maintains, and administrates the photovoltaic power plants with acquisition, financing and optimization of operating assets. Its d …
  • Urenco Ltd:企業の戦略・SWOT・財務情報
    Urenco Ltd - Strategy, SWOT and Corporate Finance Report Summary Urenco Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Swan Energy Ltd (SWANENERGY):企業の財務・戦略的SWOT分析
    Summary Swan Energy Ltd (SEL), formerly Swan Mills Ltd is a textile company that manufactures and markets cotton and polyester textile products. The company also operates through its real estate development of residential and commercial complexes and energy businesses. It operates and develops real …
  • Hochschild Mining plc:企業のM&A・事業提携・投資動向
    Hochschild Mining plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hochschild Mining plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Northwest Bancshares Inc:企業の戦略・SWOT・財務情報
    Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report Summary Northwest Bancshares Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務分析
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Electric Power Development Co Ltd (9513):電力:M&Aディール及び事業提携情報
    Summary Electric Power Development Co., Ltd. (J-Power) is a wholesale electric utility that supplies hydroelectric and thermal power. It owns and operates a network of hydroelectric, thermal, wind and geothermal power plants. The group provides electricity and transmission services to major electric …
  • TOMS Gruppen AS:企業の戦略的SWOT分析
    TOMS Gruppen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • CACI International, Inc.:企業の戦略・SWOT・財務分析
    CACI International, Inc. - Strategy, SWOT and Corporate Finance Report Summary CACI International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Challenge Group Holdings PTE. LTD.:企業の戦略・SWOT・財務情報
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • XState Resources Ltd (XST):石油・ガス:M&Aディール及び事業提携情報
    Summary XState Resources Ltd (XState Resources) is an oil and gas exploration and development company. The company’s business activities include acquisition, exploration, production and development of oil and gas assets. It holds interest in producing gas wells and associated land leases and product …
  • BASF SE (BAS)-エネルギー分野:企業M&A・提携分析
    Summary BASF SE (BASF) is a chemical company, which carries out research and development (R&D), production, marketing and sales of chemicals, plastics, crop protection products, and performance products. Its product line comprises solvents, adhesives, surfactant, organic chemicals, fuel additives, e …
  • Pathogenetix Inc-医療機器分野:企業M&A・提携分析
    Summary Pathogenetix Inc (Pathogenetix), formerly US Genomics, a subsidiary of Toxic Reports LLC is a medical device company that develops an automated system for bacterial strain typing from complex samples. The company develops products and applications based on its proprietary genome sequence sca …
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆